Get the Stockscreener App
0.2465
3.37%
-0.0086
After Hours:
.25
0.0035
+1.42%
Adial Pharmaceuticals Inc stock is traded at $0.2465, with a volume of 403.21K.
It is down -3.37% in the last 24 hours and down -20.12% over the past month.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
See More
Previous Close:
$0.2551
Open:
$0.255
24h Volume:
403.21K
Relative Volume:
0.87
Market Cap:
$6.57M
Revenue:
-
Net Income/Loss:
$-6.07M
P/E Ratio:
-0.0426
EPS:
-5.78
Net Cash Flow:
$-7.34M
1W Performance:
+7.83%
1M Performance:
-20.12%
6M Performance:
-24.59%
1Y Performance:
-77.15%
1-Day Range:
$0.2411
$0.26
1-Week Range:
$0.2165
$0.2699
52-Week Range:
$0.2165
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Name
Adial Pharmaceuticals Inc
Sector
Industry
Phone
434-422-9800
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.2465 | 6.80M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-18 | Initiated | Maxim Group | Buy |
| Oct-11-18 | Initiated | Dawson James | Buy |
Adial Pharmaceuticals Inc Stock (ADIL) Latest News
Adial Pharmaceuticals announces immediate resignation of board director - TipRanks
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr. - Investing.com Australia
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Decreases By 31.2% - Defense World
AXIM Biotechnologies (OTCMKTS:AXIM) versus Adial Pharmaceuticals (NASDAQ:ADIL) Financial Comparison - Defense World
Can Adial Pharmaceuticals Inc. stock continue upward trend - Улправда
Will Adial Pharmaceuticals Inc. stock split again soon2025 Macro Impact & Low Volatility Stock Recommendations - Улправда
Published on: 2025-12-20 18:07:08 - Улправда
Is Adial Pharmaceuticals Inc. stock cheap at current valuationMarket Activity Report & Technical Confirmation Alerts - Улправда
Published on: 2025-12-19 03:23:09 - Улправда
Will Adial Pharmaceuticals Inc. stock deliver shareholder valueStop Loss & Reliable Volume Spike Alerts - Улправда
[EFFECT] ADIAL PHARMACEUTICALS, INC. SEC Filing - Stock Titan
Adial Pharmaceuticals Earnings Notes - Trefis
Volume Recap: Why Adial Pharmaceuticals Inc stock could be next big winner2025 Momentum Check & Consistent Return Strategy Ideas - moha.gov.vn
Litchfield Hills Research Weighs in on ADIL FY2025 Earnings - Defense World
Adial Pharmaceuticals Secures $2.86M Through Warrant Agreement - MSN
Adial Pharmaceuticals, Inc. (ADIL) AI-Powered Stock Analysis - Meyka
How Adial Pharmaceuticals Inc. stock benefits from strong dollarMarket Performance Report & Weekly Return Optimization Plans - Newser
Can Adial Pharmaceuticals Inc. stock attract ESG capital inflowsPortfolio Return Summary & Low Risk Investment Opportunities - Newser
Whale Trades: Can Adial Pharmaceuticals Inc. stock continue upward trendPortfolio Update Summary & Low Risk Growth Stock Ideas - moha.gov.vn
Are Smart Investors Making the Right Decision? Adial Pharmaceuticals Inc (ADIL) - Setenews
Adial Pharmaceuticals raises $2.86 million through warrant exercise By Investing.com - Investing.com Nigeria
Adial Pharmaceuticals (ADIL) Announces Warrant Inducement Agreem - GuruFocus
Adial Pharmaceuticals raises $2.86 million through warrant exercise - Investing.com
Adial Pharmaceuticals Enters Warrant Inducement Agreement for $2.86 Million Capital Raise - Quiver Quantitative
Adial Pharmaceuticals (NASDAQ: ADIL) enters $2.86M inducement at $0.31 exercise price - Stock Titan
Is Adial Pharmaceuticals Inc a good long term investmentMoving Average Crossovers & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in
Why Adial Pharmaceuticals Inc. stock could rally in 20252025 Year in Review & Expert Verified Movement Alerts - newser.com
Will Adial Pharmaceuticals Inc. stock deliver strong dividend growthJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Why Adial Pharmaceuticals Inc. stock could benefit from AI revolutionProfit Target & Safe Capital Growth Plans - newser.com
What high frequency data says about Adial Pharmaceuticals Inc.Quarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Detecting price anomalies in Adial Pharmaceuticals Inc. with AIJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Is this a good reentry point in Adial Pharmaceuticals Inc.July 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - MarketScreener
Will Adial Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 Drop Watch & Verified Technical Trade Signals - newser.com
Forecasting Adial Pharmaceuticals Inc. price range with options data2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Can Adial Pharmaceuticals Inc. stock withstand economic slowdownJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
Will Adial Pharmaceuticals Inc. stock continue upward momentumStock Surge & Reliable Price Breakout Signals - newser.com
Adial Pharmaceuticals' Loss Shrinks As Hopes For AD04 Grow - Finimize
Adial Pharmaceuticals Inc Stock (ADIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):